北京键凯科技股份有限公司2025年年度业绩预告

Core Viewpoint - Beijing JianKai Technology Co., Ltd. anticipates significant growth in its 2025 annual performance, with substantial increases in both revenue and net profit compared to the previous year [2][4]. Performance Forecast - The company expects to achieve an operating revenue of approximately 315 million yuan in 2025, representing an increase of 87.90 million yuan, or 38.71%, compared to the previous year [2][4]. - The projected net profit attributable to the parent company is estimated to be between 60 million and 66 million yuan, an increase of 30.16 million to 36.16 million yuan, or 101.09% to 121.20% year-on-year [2][4]. - The net profit attributable to the parent company after deducting non-recurring gains and losses is expected to be between 45 million and 50 million yuan, reflecting an increase of 25.52 million to 30.52 million yuan, or 131.01% to 156.68% year-on-year [2][4]. Previous Year Performance - In the previous year, the company reported an operating revenue of 227.10 million yuan [6]. - The total profit was 32.67 million yuan, with a net profit attributable to the parent company of 29.84 million yuan, and a net profit after deducting non-recurring gains and losses of 19.48 million yuan [6]. Reasons for Performance Changes - The anticipated growth in 2025 is primarily attributed to increased order revenue from the sales volume of new drug products launched by overseas clients [8].